Sinocare invests USD7.9 million in EoFlow for diabetic sensor-pump JV

Sinocare will invest KRW9.2 billion (USD7.9 million) in EoFlow for a 1.5% stake and form a joint venture in Changsha, China, to integrate blood glucose monitoring with insulin pumps.

“Sinocare intends to invest KRW9.2 billion (USD7.9 million) in South Korean insulin pump producer EoFlow and set up a joint venture in central China.”yicaiglobal.com

• 1 source
• yicaiglobal.comSinocare Pours USD7.9 Million Into EoFlow to Develop a Diabetic Sensor-Pump SolutionTang ShihuaOct 27, 2021

Summarized from public sources; check the original articles before acting on it.